UroGen Pharma Ltd (URGN)
13.21
-0.57
(-4.14%)
USD |
NASDAQ |
May 16, 16:00
13.21
0.00 (0.00%)
After-Hours: 16:44
UroGen Pharma Gross Profit Margin (Quarterly): 90.28% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.28% |
| September 30, 2023 | 88.65% |
| June 30, 2023 | 88.44% |
| March 31, 2023 | 86.83% |
| December 31, 2022 | 87.49% |
| September 30, 2022 | 87.45% |
| June 30, 2022 | 88.88% |
| March 31, 2022 | 88.76% |
| December 31, 2021 | 90.18% |
| September 30, 2021 | 89.04% |
| June 30, 2021 | 89.05% |
| March 31, 2021 | 88.02% |
| December 31, 2020 | 91.82% |
| September 30, 2020 | 91.07% |
| June 30, 2020 | 87.10% |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -272.8% |
| June 30, 2018 | 12.64% |
| March 31, 2018 | 10.60% |
| December 31, 2017 | 12.23% |
| September 30, 2017 | 96.22% |
| June 30, 2017 | |
| March 31, 2017 | 5.26% |
| December 31, 2016 | 99.84% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
86.83%
Minimum
Mar 2023
91.82%
Maximum
Dec 2020
88.87%
Average
88.76%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
| Agenus Inc | -57.23% |
| Exelixis Inc | 95.00% |
| Geron Corp | -- |
| Protalix BioTherapeutics Inc | 30.58% |
| InfuSystems Holdings Inc | 51.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -71.41% |
| Return on Invested Capital | -1.30K% |
| Profit Margin (Quarterly) | -110.6% |
| Operating Margin (Quarterly) | -62.09% |
| Return on Net Operating Assets | -465.9% |